Italian Pharmaceuticals & Biotech Potentially Undervalued Companies

Regeneron Pharmaceuticals

Market Cap: €59.3b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Sanofi

Market Cap: €109.7b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Bayer

Market Cap: €19.8b

Operates as a life science company worldwide.

Viatris

Market Cap: €9.0b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Merck

Market Cap: €199.2b

Operates as a healthcare company worldwide.

Merck KGaA

Market Cap: €50.1b

Operates as a science and technology company in Germany.

Thermo Fisher Scientific

Market Cap: €165.4b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

CureVac

Market Cap: €715.6m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Evotec

Market Cap: €950.4m

Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €169.9m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Gilead Sciences

Market Cap: €129.1b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Incyte

Market Cap: €11.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Pfizer

Market Cap: €124.3b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Gerresheimer

Market Cap: €1.8b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Bristol-Myers Squibb

Market Cap: €103.2b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.5b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Agilent Technologies

Market Cap: €29.3b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Biogen

Market Cap: €16.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €9.6b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Organon

Market Cap: €2.9b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Zoetis

Market Cap: €66.7b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Orion Oyj

Market Cap: €6.7b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Eli Lilly

Market Cap: €657.7b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Swedish Orphan Biovitrum

Market Cap: €87.3b

An integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

AbbVie

Market Cap: €309.7b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Grifols

Market Cap: €4.8b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Johnson & Johnson

Market Cap: €365.6b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

BioMarin Pharmaceutical

Market Cap: €10.8b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Danaher

Market Cap: €135.0b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

SCHOTT Pharma KGaA

Market Cap: €3.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.